$SATS·4

EchoStar CORP · Mar 14, 4:54 PM ET

EchoStar CORP 4

4 · EchoStar CORP · Filed Mar 14, 2016

Insider Transaction Report

Form 4
Period: 2016-03-10
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2016-03-10$36.43/sh+1,000$36,4301,146 total
  • Sale

    Class A Common Stock

    2016-03-10$45.28/sh1,000$45,280146 total
  • Exercise/Conversion

    Class A Common Stock

    2016-03-11$36.43/sh+1,000$36,4301,146 total
  • Sale

    Class A Common Stock

    2016-03-11$45.67/sh1,000$45,670146 total
  • Exercise/Conversion

    Non-Employee Director Stock Option

    2016-03-101,0001,000 total
    Exercise: $36.43From: 2011-06-30Exp: 2016-06-30Class A Common Stock (1,000 underlying)
  • Exercise/Conversion

    Non-Employee Director Stock Option

    2016-03-111,0000 total
    Exercise: $36.43From: 2011-06-30Exp: 2016-06-30Class A Common Stock (1,000 underlying)
Footnotes (4)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2016.
  • [F2]The price reported is the weighted average price. The shares reported in this transaction were sold at prices ranging between $45.05 and $45.75. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the indicated range.
  • [F3]The price reported is the weighted average price. The shares reported in this transaction were sold at prices ranging between $45.31 and $45.90. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the indicated range.
  • [F4]The shares underlying the option were 100% vested upon the date of grant.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT